Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_assertion type Assertion NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_head.
- NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_assertion description "[A significant relation was observed between presence of chromosome abnormalities and the following hematologic parameters: clinical stage III (p = 0.0212), bone marrow (BM) plasma cell infiltration greater than 30% (p = 0.0379), presence of bone lesions (p = 0.0051), and beta 2-microglobulin levels greater than 4,000 md/dl (p = 0.0194).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_provenance.
- NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_assertion evidence source_evidence_literature NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_provenance.
- NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_assertion SIO_000772 7828155 NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_provenance.
- NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_assertion wasDerivedFrom befree-20150227 NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_provenance.
- NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_assertion wasGeneratedBy ECO_0000203 NP258469.RAFPs3I9wIgGxyGnyU4RfSL2mjAIZLWKj1e9y69-fzhBs130_provenance.